PF-06291874

DRUG4 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus, Type IIHealthyType 2 Diabetes Mellitus

Phase 1

Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects

CompletedNCT01794364

Start: 2013-01-31End: 2013-03-31Updated: 2013-04-04

PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients

CompletedNCT01856595

PfizerDiabetes Mellitus, Type 2

Start: 2013-05-13End: 2014-03-01Updated: 2018-11-01

Phase 2

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

CompletedNCT02175121

PfizerDiabetes Mellitus, Type II

Start: 2014-08-31End: 2015-03-31Updated: 2016-06-15

A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin

CompletedNCT02554877

PfizerType 2 Diabetes Mellitus

Start: 2015-10-31End: 2016-08-31Updated: 2017-08-07